Crixivan and Biaxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Crixivan (indinavir sulfate) and Biaxin (clarithromycin). Common drug interactions include blood urea increased among females and diabetic ketoacidosis among males.

The phase IV clinical study analyzes what interactions people have when they take Crixivan and Biaxin. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Crixivan?

Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.

What is Biaxin?

Biaxin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 14,248 Biaxin users. Check the latest studies of Biaxin.



On Jul, 04, 2026

56 people who take Crixivan and Biaxin together, and have interactions are studied.

Crixivan and Biaxin drug interactions.

What are the common drug interactions of Crixivan and Biaxin, by gender? *:

female:

  1. Blood urea increased
  2. Cholecystitis (infection of gallbladder)
  3. Diarrhoea
  4. Gastric dilatation (a twisted stomach)
  5. Haematuria present (presence of blood in urine due to trauma)
  6. Lymphoma (cancer that begins in immune system cells)
  7. Multiple myeloma (cancer of the plasma cells)
  8. Oedema (fluid collection in tissue)
  9. Proteinuria present
  10. Pyrexia (fever)

male:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Vomiting
  3. Anaemia (lack of blood)
  4. Blood amylase increased
  5. Blood glucose increased
  6. Fat disorder (inability to produce fat utilize enzyme)
  7. Hypercholesterolaemia (high levels of cholesterol in the blood)
  8. Hypertriglyceridaemia (excess of triglycerides in the blood)
  9. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  10. Lactic acidosis (low ph in body tissues)

What are the common drug interactions of Crixivan and Biaxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pancreatitis necrotising (inflammation of the pancreas cause death of tissue in pancreas)

20-29:

n/a

30-39:

  1. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  2. Oedema peripheral (superficial swelling)
  3. Pulmonary hypertension (increase in blood pressure in the lung artery)
  4. Right ventricular failure (right half of the heart fails to work)
  5. Abdominal distension
  6. Blood glucose increased
  7. Blood triglycerides increased
  8. Cholecystitis (infection of gallbladder)
  9. Depression
  10. Gastric dilatation (a twisted stomach)

40-49:

  1. Anaemia (lack of blood)
  2. Acute abdomen
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Depressed level of consciousness
  5. Hepatitis (inflammation of the liver)
  6. Hepatocellular damage (liver damage)
  7. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Blood creatinine increased

50-59:

  1. Renal failure (kidney dysfunction)
  2. Blood creatinine increased
  3. Blood urea increased
  4. Diarrhoea
  5. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  6. Haematuria present (presence of blood in urine due to trauma)
  7. Multiple myeloma (cancer of the plasma cells)
  8. Proteinuria present
  9. Vomiting
  10. Blood glucose increased

60+:

  1. Abdominal pain
  2. Blood amylase increased
  3. Fat disorder (inability to produce fat utilize enzyme)
  4. Hyperglycaemia (high blood sugar)
  5. Taste disturbance
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  8. Lipase increased
  9. Nausea (feeling of having an urge to vomit)
  10. Pancreatitis (inflammation of pancreas)

* Approximation only. Some reports may have incomplete information.

Do you take Crixivan and Biaxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Crixivan and Biaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Biaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crixivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Biaxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on indinavir sulfate and clarithromycin (the active ingredients of Crixivan and Biaxin, respectively), and Crixivan and Biaxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: